IPO Boutique

MeiraGTx Holdings plc IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on MeiraGTx Holdings plc, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
MeiraGTx Holdings plcMGTX -
NASDAQ
$14.00-$16.00 $15.00 $15.105 million6/8/2018
BofA Merrill Lynch, Barclays, Evercore ISI
Co-Manager(s):
Chardan
Health Care
Filing(s):

Filed 2018-05-14
Terms Added 2018-05-28
Final Prospectus 2018-06-08



MeiraGTx Holdings plc Quote & Chart - Click for current quote - MGTX

About MeiraGTx Holdings plc (adapted from MeiraGTx Holdings plc prospectus):
They are a vertically integrated, clinical stage gene therapy company with four ongoing clinical programs and a broad pipeline of preclinical and research programs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "MGTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved